-
McKesson showcases new central fill solution at ASHP Mid-Year Clinical Meeting
LAS VEGAS – McKesson's High Volume Solutions group on Friday announced the launch of Central Fill as a Service (CFaaS), a McKesson-operated, centralized solution that allows pharmacies to use central fill without the investment in equipment, inventory or staffing (other than a pharmacist). Instead of the traditional central fill model that requires significant upfront investment, CFaaS is available to customers through a per-prescription fee that can dramatically reduce the pharmacy’s per-prescription cost to dispense.
-
Genteel alternate-site lancet device gains FDA clearance
MIDLAND, Texas — Genteel on Tuesday announced clearance by the U.S. Food & Drug Administration for its “gentle” lancing device. Genteel is the only FDA-cleared standalone lancing device that performs ample blood draw from other body sites as well as fingers.
